
Cationic liposome–DNA complexes (CLDC) adjuvant enhances the immunogenicity and cross-protective efficacy of a pre-pandemic influenza A H5N1 vaccine in mice
Keywords: Influenza A H5N1 virus; Adjuvant; CLDC; Cross-clade protection; Dose-sparing; Antibody responses; CD4+ T-cell immunity